Home > Archive > 2001 >

Volume 20, Number 3 (September)

Ramadan Fasting (pages 7-14)

Awad Mohamed Ahmed, M.B.B.S., M.D.

Religious fasting in a person with diabetes can lead to swings in blood glucose levels. Dr. Ahmed explains how fasting during Ramadan affects glycemic control and discusses how you can help your Muslim patients to fast safely.
Diabetes in specific populationsMuslims
Management strategies and toolsStrategies for glycemic control

The Polycystic Ovary Syndrome and Insulin Resistance (pages 16-23)

Nausheen Akhter, B.A., and John E. Nestler, M.D.

The American College of Endocrinology and the American Association of Clinical Endocrinologists recently listed polycystic ovary syndrome as a high-risk factor for diabetes. In this timely article, the authors review the symptoms and treatments of this underdiagnosed disorder.
Complications and comorbiditiesPolycystic ovary syndrome

Nateglinide (pages 24-28)

Priscilla A. Hollander, M.D., and James E. Foley, Ph.D.

Postmeal high blood glucose levels are associated with worsened glycemic control and many diabetes complications. In this article, the authors discuss how some of your patients may benefit from nateglinide (brand name Starlix) and how nateglinide works to reduce postmeal blood glucose levels.
Drug treatmentMeglitinides

Variations on Metformin: "Glucohelp or Glucohype"? (pages 30-33)

William L. Isley, M.D., and Charles A. Reasner, M.D.

Glucophage XR and Glucovance, the new formulations of metformin, may change the way you and your patients manage their diabetes. Two physicians offer contrasting views on the benefits of these drugs.
Drug treatmentMetformin

Clinical Targets in Diabetes Mellitus (pages 34-37)

Patricio A. Pazmi

Keeping patients’ blood glucose, blood pressure, and lipid levels in line with current recommendations is important to prevent complications. Dr. Pazmi
Management strategies and toolsStrategies for glycemic control